Earlier Monday, the U.S. FDA approved Bausch + Lomb's (BlCO) eye surgery product, the Teneo Excimer Laser Platform, to conduct a surgical procedure called keratomileusis (LASIK).

Bausch + Lomb has continued to focus on innovation and quality in eye care products, from contact lenses to lubricant eye drops. MOST STUDIED BRAND: PreserVision is the most studied eye vitamin ...

The company recently invested an additional €90m to expand its capabilities at its contact lens manufacturing plant in ...

Bausch + Lomb has continued to focus on innovation and quality in eye care products, from contact lenses to lubricant eye drops. MOST STUDIED BRAND: PreserVision is the most studied eye vitamin ...

Bausch + Lomb sells contact lenses, eye drops and other products that generate a steady revenue stream. Bausch Health’s main drug, the gut antibiotic Xifaxan, will likely face generic ...

Bausch + Lomb sells contact lenses, eye drops and other products that generate a steady revenue stream. Bausch Health’s main drug, the gut antibiotic Xifaxan, will likely face generic competition in ...

Papa took over as the new CEO of Bausch & Lomb, and oversaw the $2.5bn acquisition of the dry eye disease therapy XIIDRA and other ophthalmology assets from Swiss Pharma giant Novartis AG (NVS ...

Emergent appoints former Bausch + Lomb CEO to head company February 21, 2024 The U.S. Food and Drug Administration (FDA) on Wednesday warned consumers not to use unapproved eye drops that closely ...

Meet the new Valeant: Drugmaker drops tainted name to become Bausch Health in July rebrand A buyout would be one of the largest private equity healthcare deals of the year as Bausch + Lomb has an ...

Elios Vision former chairman and CEO Elliot Friedman said: “Bausch + Lomb’s extensive reach in cataract surgery will introduce ELIOS to a broader range of eye care professionals and help ...